Literature DB >> 8193587

Sequence characterization of cardiotoxins from Taiwan cobra: isolation of a new isoform.

C C Hung1, S H Wu, S H Chiou.   

Abstract

Cardiotoxins (or called cytotoxins) are a group of very basic polypeptides present in some snake venoms, which are especially abundant in Formosan cobras. Several cardiotoxins with distinct pharmacological and biochemical properties were isolated and purified from the Taiwan cobra venom (Naja naja atra) by employing sequentially preparative-scale cation-exchange chromatography on TSK CM-650 coupled with the improved separation of toxin components on reversed-phase HPLC based on their hydrophobicity. The complete sequences of six cardiotoxin analogues, including one novel isoform never reported previously in this venom, were determined by N-terminal Edman degradation with the automatic pulsed-liquid phase sequencer and comparison of amino-acid compositions of purified toxin components. This novel cardiotoxin, a basic polypeptide of pI 10.13, comprises about 5% of total crude venom. It consists of 60 amino-acid residues with four disulfide bonds and shares about 80-92% sequence identity with several cytotoxins isolated from varied sources of different snakes. A systematic structure comparison of six major cardiotoxin isoforms was made by the secondary-structure predictions and hydropathy profiles based on their primary sequences. It is of interest to find that some subtle differences among these natural cardiotoxin analogues may lie in the intrinsic differences of the surface hydrophobicity of these isotoxins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8193587

Source DB:  PubMed          Journal:  Biochem Mol Biol Int        ISSN: 1039-9712


  2 in total

1.  Separation and structure-function studies of Taiwan cobra cardiotoxins.

Authors:  Shinne-Ren Lin; Long-Sen Chang; Kee-Lung Chang
Journal:  J Protein Chem       Date:  2002-02

2.  Ameliorating Adriamycin-Induced Chronic Kidney Disease in Rats by Orally Administrated Cardiotoxin from Naja naja atra Venom.

Authors:  Zhi-Hui Ding; Li-Min Xu; Shu-Zhi Wang; Jian-Qun Kou; Yin-Li Xu; Cao-Xin Chen; Hong-Pei Yu; Zheng-Hong Qin; Yan Xie
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-30       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.